New York, NY -- (SBWIRE) -- 01/29/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Santander Mexico Fincl Gp SAB deCV (ADR) (NYSE:BSMX), Houston American Energy Corporation (NYSEMKT:HUSA), BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX), Quiksilver, Inc (NYSE:ZQK)
Santander Mexico Fincl Gp SAB deCV (ADR) (NYSE:BSMX) showed a volume of 2.04 million shares by the end of last trade whereas the average volume of the stock remained 1.81 million shares. The stock opened the session at $12.09 but then moved to $12.09. At that price, the stock showed a positive performance of 1.00%. Santander Mexico Financial Group SAB de CV, formerly Grupo Financiero Santander SAB de CV, is a Mexico-based financial institution. The Company is primarily engaged, through its subsidiaries, in the provision of multiple banking services, securities brokerage, financial advice services.
Will BSMX Continue To Move Higher? Find Out Here
Houston American Energy Corporation (NYSEMKT:HUSA) opened the session at $0.36 and closed the session at $0.428. The stock showed a positive performance of 18.86% in previous trading session. Traded with volume of 2.04 million shares in the prior session and the average volume of the stock remained 316,076.00 shares.Houston American Energy Corp (Houston American) is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties in the United States Gulf Coast region and in South America.
For How Long HUSA will fight for Profitability? Read This Trend Analysis report
BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) opened the session at $9.37 and closed the session at $10.04. The stock showed a positive performance of 2.34% in previous trading session. Traded with volume of 2.02 million shares in the prior session and the average volume of the stock remained 1.47 million shares. The beta of the stock remained 3.03. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases.
Why Should Investors Buy BCRX After The Recent Gain? Just Go Here and Find Out
Quiksilver, Inc (NYSE:ZQK) the stock advanced 2.03% and finished the session at $7.53. Traded with volume of 1.98 million shares in the prior session and the average volume of the stock remained 1.64 million shares. The beta of the stock remained 2.74. Quiksilver, Inc. is a diversified company that designs, develops and distributes branded apparel, footwear, accessories and related products, catering to the casual, youth lifestyle associated with the sports of surfing, skateboarding and snowboarding.
Will ZQK Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)